Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Bushlin, Ittai ^a   Gupta, Achla ^a   Stockton, Steven D ^a   Miller, Lydia K ^a   Devi, Lakshmi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; DELTA OPIATE RECEPTOR;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; CEREBELLUM; CHRONIC PAIN; CONTROLLED STUDY; CORPUS STRIATUM; DIMERIZATION; HIPPOCAMPUS; HYPOTHALAMUS; LIGAND BINDING; MALE; MESENCEPHALON; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; PERIPHERAL NERVE INJURY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION;

EID: 84871343938     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049789     Document Type: Article

References (96)

1. Finnerup NB, Sindrup SH, Jensen TS, (2010) The evidence for pharmacological treatment of neuropathic pain. Pain 150: 573-581.
2. O'Connor AB, Dworkin RH, (2009) Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 122: S22-32.
3. Bausch SB, Patterson TA, Appleyard SM, Chavkin C, (1995) Immunocytochemical localization of delta opioid receptors in mouse brain. J Chem Neuroanat 8: 175-189.
4. Hohmann AG, Briley EM, Herkenham M, (1999) Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res 822: 17-25.
5. Maldonado R, Valverde O, (2003) Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses. Eur Neuropsychopharmacol 13: 401-410.
6. Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, et al. (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20: 287-294.
7. Pan HL, Wu ZZ, Zhou HY, Chen SR, Zhang HM, et al. (2008) Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther 117: 141-161.
8. Salio C, Fischer J, Franzoni MF, Conrath M, (2002) Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. Neuroscience 110: 755-764.
9. Svizenska I, Dubovy P, Sulcova A, (2008) Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures-a short review. Pharmacol Biochem Behav 90: 501-511.
10. Wilson-Poe AR, Morgan MM, Aicher SA, Hegarty DM, (2012) Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray. Neuroscience 213: 191-200.
11. Bie B, Pan ZZ, (2007) Trafficking of central opioid receptors and descending pain inhibition. Mol Pain 3: 37.
12. Pertwee RG, (2001) Cannabinoid receptors and pain. Prog Neurobiol 63: 569-611.
13. Bushlin I, Rozenfeld R, Devi LA, (2010) Cannabinoid-opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol 10: 80-86.
14. Welch SP, (2009) Interaction of the cannabinoid and opioid systems in the modulation of nociception. Int Rev Psychiatry 21: 143-151.
15. Parolaro D, Rubino T, Vigano D, Massi P, Guidali C, et al. (2010) Cellular mechanisms underlying the interaction between cannabinoid and opioid system. Curr Drug Targets 11: 393-405.
16. Perrine SA, Hoshaw BA, Unterwald EM, (2006) Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br J Pharmacol 147: 864-872.
17. Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, et al. (2004) Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J Pharmacol Sci 95: 374-380.
18. Bambico FR, Katz N, Debonnel G, Gobbi G, (2007) Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 27: 11700-11711.
19. Lin HC, Mao SC, Su CL, Gean PW, (2009) The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cereb Cortex 19: 165-175.
20. Rea K, Roche M, Finn DP, (2007) Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate. Br J Pharmacol 152: 633-648.
21. Uriguen L, Berrendero F, Ledent C, Maldonado R, Manzanares J, (2005) Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice. Eur J Neurosci 22: 2106-2110.
22. Rozenfeld R, Bushlin I, Gomes I, Tzavaras N, Gupta A, et al. (2012) Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. PLoS One 7: e29239.
23. Berrendero F, Mendizabal V, Murtra P, Kieffer BL, Maldonado R, (2003) Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice. Eur J Neurosci 18: 2197-2202.
24. Berrendero F, Maldonado R, (2002) Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 163: 111-117.
25. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, et al. (2010) Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 3: ra54.
26. Rozenfeld R, Gupta A, Gagnidze K, Lim MP, Gomes I, et al. (2011) AT1R-CB(1)R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. Embo J 30: 2350-2363.
27. Rios C, Gomes I, Devi LA, (2006) mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol 148: 387-395.
28. Ji RR, Zhang Q, Law PY, Low HH, Elde R, et al. (1995) Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15: 8156-8166.
29. Kabli N, Cahill CM, (2007) Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 127: 84-93.
30. Li JL, Kaneko T, Mizuno N, (1996) Effects of peripheral nerve ligation on expression of mu-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion neurons of the rat. Neurosci Lett 214: 91-94.
31. Puehler W, Zollner C, Brack A, Shaqura MA, Krause H, et al. (2004) Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 129: 473-479.
32. Truong W, Cheng C, Xu QG, Li XQ, Zochodne DW, (2003) Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann Neurol 53: 366-375.
33. Walczak JS, Pichette V, Leblond F, Desbiens K, Beaulieu P, (2005) Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience 132: 1093-1102.
34. Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, et al. (2009) Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141: 283-291.
35. Rashid MH, Inoue M, Toda K, Ueda H, (2004) Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J Pharmacol Exp Ther 309: 380-387.
36. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, et al. (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci U S A 95: 7157-7162.
37. Besse D, Lombard MC, Perrot S, Besson JM, (1992) Regulation of opioid binding sites in the superficial dorsal horn of the rat spinal cord following loose ligation of the sciatic nerve: comparison with sciatic nerve section and lumbar dorsal rhizotomy. Neuroscience 50: 921-933.
38. Stevens CW, Kajander KC, Bennett GJ, Seybold VS, (1991) Bilateral and differential changes in spinal mu, delta and kappa opioid binding in rats with a painful, unilateral neuropathy. Pain 46: 315-326.
39. Datta S, Chatterjee K, Kline RHt, Wiley RG, (2010) Behavioral and anatomical characterization of the bilateral sciatic nerve chronic constriction (bCCI) injury: correlation of anatomic changes and responses to cold stimuli. Mol Pain 6: 7.
40. Holdridge SV, Cahill CM, (2007) Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Eur J Pain 11: 685-693.
41. Porreca F, Tang QB, Bian D, Riedl M, Elde R, et al. (1998) Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Res 795: 197-203.
42. Robertson B, Schulte G, Elde R, Grant G, (1999) Effects of sciatic nerve injuries on delta-opioid receptor and substance P immunoreactivities in the superficial dorsal horn of the rat. Eur J Pain 3: 115-129.
43. Stone LS, Vulchanova L, Riedl MS, Williams FG, Wilcox GL, et al. (2004) Effects of peripheral nerve injury on delta opioid receptor (DOR) immunoreactivity in the rat spinal cord. Neurosci Lett 361: 208-211.
44. Tseng TJ, Chen CC, Hsieh YL, Hsieh ST, (2008) Influences of surgical decompression on the dorsal horn after chronic constriction injury: changes in peptidergic and delta-opioid receptor (+) nerve terminals. Neuroscience 156: 758-768.
45. Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, et al. (2001) Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 21: 1779-1786.
46. Lim G, Sung B, Ji RR, Mao J, (2003) Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats. Pain 105: 275-283.
47. Mitrirattanakul S, Ramakul N, Guerrero AV, Matsuka Y, Ono T, et al. (2006) Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain 126: 102-114.
48. Wang S, Lim G, Mao J, Sung B, Yang L, et al. (2007) Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid-1 receptors after peripheral nerve injury in rats. Pain 131: 96-105.
49. Paszcuk AF, Dutra RC, da Silva KA, Quintao NL, Campos MM, et al. (2011) Cannabinoid agonists inhibit neuropathic pain induced by brachial plexus avulsion in mice by affecting glial cells and MAP kinases. PLoS One 6: e24034.
50. Pertwee RG, (2009) Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 156: 397-411.
51. Saade NE, Jabbur SJ, (2008) Nociceptive behavior in animal models for peripheral neuropathy: spinal and supraspinal mechanisms. Prog Neurobiol 86: 22-47.
52. Seifert F, Maihofner C, (2009) Central mechanisms of experimental and chronic neuropathic pain: findings from functional imaging studies. Cell Mol Life Sci 66: 375-390.
53. Jutkiewicz EM, Torregrossa MM, Sobczyk-Kojiro K, Mosberg HI, Folk JE, et al. (2006) Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. Eur J Pharmacol 531: 151-159.
54. Saitoh A, Sugiyama A, Nemoto T, Fujii H, Wada K, et al. (2011) The novel delta opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions. Behav Brain Res 223: 271-279.
55. Narita M, Kuzumaki N, Kaneko C, Hareyama N, Miyatake M, et al. (2006) Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction. J Neurochem 97: 1369-1378.
56. Saitoh A, Yoshikawa Y, Onodera K, Kamei J, (2005) Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats. Psychopharmacology (Berl) 182: 327-334.
57. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, et al. (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25: 195-200.
58. Rodriguez de Fonseca F, Cebeira M, Ramos JA, Martin M, Fernandez-Ruiz JJ, (1994) Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci 54: 159-170.
59. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76-81.
60. Patel S, Hillard CJ, (2006) Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 318: 304-311.
61. Ozaki S, Narita M, Narita M, Iino M, Miyoshi K, et al. (2003) Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2. Neuroscience 116: 89-97.
62. Hoot MR, Sim-Selley LJ, Poklis JL, Abdullah RA, Scoggins KL, et al. (2010) Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice. Brain Res 1339: 18-25.
63. Knerlich-Lukoschus F, Noack M, von der Ropp-Brenner B, Lucius R, Mehdorn HM, et al. (2011) Spinal Cord Injuries Induce Changes in CB(1) Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions. J Neurotrauma 28: 619-634.
64. Chung JM, Kim HK, Chung K, (2004) Segmental spinal nerve ligation model of neuropathic pain. Methods Mol Med 99: 35-45.
65. Kim SH, Chung JM, (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: 355-363.
66. Beltramo M, Bernardini N, Bertorelli R, Campanella M, Nicolussi E, et al. (2006) CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur J Neurosci 23: 1530-1538.
67. Jhaveri MD, Richardson D, Kendall DA, Barrett DA, Chapman V, (2006) Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J Neurosci 26: 13318-13327.
68. Scott DA, Wright CE, Angus JA, (2004) Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. Pain 109: 124-131.
69. Liu CN, Wall PD, Ben-Dor E, Michaelis M, Amir R, et al. (2000) Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury. Pain 85: 503-521.
70. Wu G, Ringkamp M, Hartke TV, Murinson BB, Campbell JN, et al. (2001) Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J Neurosci 21: RC140.
71. Suzuki T, Amata M, Sakaue G, Nishimura S, Inoue T, et al. (2007) Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression. Anesth Analg 104: 1570-1577, table of contents.
72. Hungund BL, Vinod KY, Kassir SA, Basavarajappa BS, Yalamanchili R, et al. (2004) Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 9: 184-190.
73. Vinod KY, Arango V, Xie S, Kassir SA, Mann JJ, et al. (2005) Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol Psychiatry 57: 480-486.
74. Dubois D, Gendron L, (2010) Delta opioid receptor-mediated analgesia is not altered in preprotachykinin A knockout mice. Eur J Neurosci 32: 1921-1929.
75. Mackie K, (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 168: 299-325.
76. Pertwee RG, (2005) The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J 7: E625-654.
77. Springael JY, Urizar E, Costagliola S, Vassart G, Parmentier M, (2007) Allosteric properties of G protein-coupled receptor oligomers. Pharmacol. Ther 115: 410-418.
78. Kathmann M, Flau K, Redmer A, Trankle C, Schlicker E, (2006) Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn Schmiedebergs Arch Pharmacol 372: 354-361.
79. Gomes I, Ijzerman AP, Ye K, Maillet EL, Devi LA, (2011) G protein-coupled receptor heterodimerization: A role in allosteric modulation of ligand-mediated receptor binding. Mol Pharmacol 9: 1044-52.
80. Rozenfeld R, Devi LA, (2010) Receptor heteromerization and drug discovery. Trends Pharmacol Sci 31: 124-130.
81. Ferré S, Navarro G, Casadó V, Cortés A, Mallol J, Canela EI, Lluís C, Franco R, (2010) G protein-coupled receptor heteromers as new targets for drug development. Prog Mol Biol Transl Sci 91: 41-52.
82. Gomes I, Gupta A, Devi LA, (2012) G protein-coupled receptor heteromer regualtion in disease. Methods in Enzymology (in press).
83. Abul-Husn NS, Sutak M, Milne B, Jhamandas K, (2007) Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists. Br J Pharmacol 151: 877-887.
84. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, et al. (2004) A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101: 5135-5139.
85. Daniels DJ, Lenard NR, Etienne CL, Law PY, Roerig SC, et al. (2005) Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci U S A 102: 19208-19213.
86. He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, et al. (2011) Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation. Neuron 69: 120-131.
87. Pei L, Li S, Wang M, Diwan M, Anisman H, et al. (2010) Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat Med 16: 1393-1395.
88. Berg KA, Rowan MP, Gupta A, Sanchez TA, Silva M, Gomes I, McGuire BA, Portoghese PS, Hargreaves KM, Devi LA, Clarke WP, (2012) Allosteric Interactions between Delta and Kappa Opioid Receptors in Peripheral Sensory Neurons. Mol. Pharmacol 81: 264-72.
89. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL, (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63.
90. Dixon WJ, (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20: 441-462.
91. Lim MP, Devi LA, Rozenfeld R, (2011) Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. Cell Death Dis 9: e170.
92. Takahashi KA, Castillo PE, (2006) The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 139: 795-802.
93. Gupta A, Decaillot FM, Gomes I, Tkalych O, Heimann AS, et al. (2007) Conformation state-sensitive antibodies to G-protein-coupled receptors. J Biol Chem 282: 5116-5124.
94. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, et al. (2000) Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci 20: RC110.
95. Harrison C, Traynor JR, (2003) The [35S]GTPgammaS binding assay: approaches and applications in pharmacology. Life Sci 74: 489-508.
96. Lazareno S, (1999) Measurement of agonist-stimulated [35S]GTP gamma S binding to cell membranes. Methods Mol Biol 106: 231-245.